Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

6th PCNE Working Symposium 2018, Fuengirola, Spain

Seamless Pharmaceutical Care - Supporting the Pharmacists' contribution to seamless transitions between care setttings

2-3 February 2018


This PCNE Working Symposium will be in Andalusia, the south of Spain. It is here where Don Quixote, the Ingenious Knight of La Mancha, was supposed to be engendered by Cervantes’s experience in prison. From time to time we might have a similar feeling of ‘fighting the windmills’, but hopefully, the science and evidence based approaches will keep us sane. We are sure the Symposium in Fuengirola will enable us to see reality more clearly and develop a more fruitful narrative than the one of Don Quixote. 

The topic of the symposium is seamless pharmaceutical care, supporting the worldwide trend in healthcare reform towards an integrated, coordinated and streamlined approach.

Seamless care describes an optimal situation where there is continuity in healthcare provision, even in the presence of many transitions. Pharmacists typically refer to the transition of patients from hospital to the ambulatory setting or vice versa, i.e. linking different levels of care (primary, secondary and tertiary). Integration of care can also, however, be seen at the horizontal level, involving multiprofessional collaboration within a single setting. We are sure there is much to explore within the seamless care framework, and we are looking forward to your participation in Fuengirola.

 

Mitja Kos (PCNE Chairman) and Nejc Horvat (PCNE Secretary)

University of Ljubljana, Faculty of pharmacy, Slovenia​

 

Keep an eye on this space. More information will be added regularly.

The preliminary program can now be downloaded here

 Abstract submission open till 15 November 2017, 24h CEST


EXTRA SYMPOSIUM - SEPARATE REGISTRATION -

Pharmaceutical care thrives best when it is provided as a remunerated service. In some European countries, this is already the case. Therefore, the day before the PCNE conference, 1st February 2018, 17.00-19.00h, SEFAC and PCNE organise a 2 hour symposium, with the title

Overcoming barriers when implementing new pharmacy services

Please note that you must register separately for this symposium. The costs are € 10.00, including coffee.

The symposium aims to provide participants with the background knowledge and tools that are needed to successfully plan the implementation of new services in community pharmacy.

The symposium starts with an overview of successful cases of cognitive pharmaceutical services implementation in some countries. Then one selected service and country will be chosen as an example to introduce some management and planning tools that participants can use throughout the workshop. Subgroups will be created for the practical part of the workshop. These will then start by analysing the current reality in their country; strength, weaknesses and opportunities. Finally, change management theory will be used to assist in the development of an implementation plan, adapted to the national reality.  

 

 Sefac logo

PCNE logo 2017


This conference is organised with support from SEFAC (Sociedad Española de Farmacia Familiar y Comunitaria) and other Spanish PCNE members:

  • Consejo General de Colegios Oficiales de Farmacéuticos de España, Madrid
  • Pharmaceutical Care Foundation España, Barcelona
  • Universidad de Granada, Facultad de Farmacia, Research group Pharmaceutical Care, Granada
  • Universidad de Barcelona. Clinical Pharmacy and Pharmacotherapy Unit, Barcelona

 

 

Pharmacist role in seamless care in community pharmacy.

Dr. Rik Ensing, the Netherlands

Abstract

Information on medication changes during hospitalization is often poorly documented and poorly transferred to the next health care provider at the time of hospital discharge. Furthermore, these changes are frequently unaccompanied by adequate patient counselling which leaves patients confused, vulnerable and at risk of drug-related problems (DRPs) post-discharge. The impact of discontinuity of pharmaceutical care at time of hospital discharge can be serious, as DRPs may result in an array of adverse outcomes ranging from patients’ discomfort or dissatisfaction to increased health care utilisation or readmission.

This poses challenges for the community pharmacist, who is responsible for the pharmaceutical care at home. It also affects patients since they abruptly need to resume their self-management post-discharge to familiarise themselves with changes in their medication regimen. Post-discharge follow-up is therefore crucial in establishing continuity of care (Figure 1) and should be part of the medication reconciliation and review process. This follow-up can be conducted over the telephone or at the patients’ home, for instance.Seamles care Ensing

During this lecture Dr. Ensing will consider the transfer from patients back to the community, the completeness of the necessary information at different time points and the challenges with implementing a post-discharge follow-up home visit in everyday community pharmacy.

 

Pharmacist role in seamless care in the hospital.

Dr. Markus Lampert, Switzerland

Abstract

The body of evidence has been growing over the last few years showing that pharmaceutical activities initiated in hospitals are effective in reducing drug-related problems at discharge but also rehospitalisation due to poor drug therapy management after discharge. In parallel also the awareness in the hospitals increases that transitions of care, in particular hospital discharge, are critical steps in a patient’s journey and that there is a responsibility for the hospitals to improve this process. Reimbursement systems with penalties for too early readmissions may trigger such developments. Different models how to support discharge from a pharmaceutical perspective have been proposed and implemented ranging from pure cognitive services to services with drug dispensing at discharge. A critical overview of these models will be given.

But also hospital admission represents a challenge. To get the “best possible medication history” is still a difficult but crucial task. Without the proper medication list at admission it is hardly possible to establish a correct and comprehensive drug therapy plan or even a pharmaceutical care plan at discharge. Medication reconciliation (MedRec) is mandatory in some European countries but not in all. Barriers and facilitators to implement MedRec will be discussed.

The lecture will also focus on how hospital and ambulatory pharmaceutical care can be linked to reach really seamless care. We will propose the MOSAIC framework for research and practice in this topic (Medicines Management Optimisation by Structured Assessment in Integrated Care). We will show and discuss the tools for risk stratification of patients and for seamless documentation of pharmaceutical interventions which were elaborated within this framework.

This symposium has two times four workshops, each lasting 4 hours. The second set of workshops (on Saturday) will build on what the previous group has done.

The aim of the workshops is:

  • To foster the work of the different working groups within PCNE
  • To make the work of the PCNE working groups relevant for care transitions (i.e. to specify some work that has been done as to make it applicable on care transitions)
  • To exchange ideas between participants
  • To generate a common view on what needs to be done (and to work towwards creating a common starting point for projects).

WS1

Medication review after discharge

Facilitators: Jacqueline Hugtenburg - Rik Ensing

The most implemented service is currently the medication review, including reconciliation, at the transfer between care settings; in this case typically at hospital admission and discharge. What needs to be done in what order? What is the aim of this review? What is the role of other health care professionals besides the pharmacist, such as doctors and nurses?

WS2

Using the PCNE DRP-classification at transitions between care settings

Facilitators: Nejc Horvat - Foppe van Mil

In the transition of patients between care settings (home-hospital-nursing home etc.), much information tends to gets lost. This often results in problems with the medications. Can the PCNE-DRP classification be used in these situations? Does it offer coding options for all types of problems that may occur, or are essential DRPs and their causes missing for these situations?

WS3

Guidelines and indicatiors for seamless care

Facilitators: Martina Teichert - Mitja Kos

Risky processes such as transitions of vulnerable patients from one healthcare setting to another need clear structures en processes to provide optimal care in an efficient way. To this guidelines are needed with recommendations for the optimal organisation of hospital discharge and transition into primary care. Together with these guidelines indicators should be developed that monitor and stimulate the implemenation of guideline recommendations into daily practice.

This workshop focusses on relevant structures and processes within seamless care, defined by the workshop participants. Together we will identify meaningful aspects and translate these into indicators that are valid, reliable, mesurable and sensitive for improvements. This basic set of structures and processes with indicators can help the participants to develop guidelines within their own settings.

WS 4

Core outcome Set (COS) usable at hospital discharge

Facilitators: Veerle Foulon - Charlotte Rossing

There are many activities under development that that aim to optimize continuity of the management of medication at patient discharge from hospital. Interventions at discharge of a patient from hospital to home are ultimately meant to improve the quality of life of a patient, decrease readmissions and the financial burden on the health care system. But, what other outcomes of interventions at hospital discharge are important? Is it possible to define a Core Outcome Set, that will help to measure the impact of interventions at hospital discharge on the patient and his or her environment?

A paper (PDF for print) version can be downloaded here

The preliminary program looks as follows:

Program Thursday 1 February 2018

17.00-19.00h

SEFAC-PCNE symposium (extra registration fee)

Remunerated pharmacy services in Europe

Organisation: Dr. Filipa Alves da Costa, Dr. Lola Murillo

 

Program Friday 2 February 2018

8.00-10.00

Registration

10.00-10.15

Opening

   

10.15-10.45

Plenary lecture: Pharmacist role in seamless care in community pharmacy. Dr. Rik Ensing, the Netherlands. See tab 'Lectures' for the abstract.

10.45-11.15

Plenary lecture: Pharmacist role in seamless care in the hospital. Dr. Markus Lampert, Switzerland. See tab 'Lectures for the abstract.

11.15-11.30

Coffee break

   

11.30-13.00

Oral communications (Chair Dr. Ana Molinero)

13.00-15.00

Lunch & posters (and PCNE Soapbox only for PCNE members)

15.00-19.00

Workshops series 1-4

WS1: Medication review after hospital discharge

WS2: Use of PCNE DRP-classification at transition

WS3: Guidelines and indicators for seamless care

WS4: Core outcome Set (COS) usable at discharge

19.00-19.30

Break

19.30-23.00

PCNE Social event

(dinner and flamenco show at a Caseta de Feria)

(Separate registration)

 

Program Saturday 3 February 2018

9.00-13.00

Workshops series 1-4 (repeated)

WS1: Medication review after hospital discharge

WS2: Use of PCNE DRP-classification at transition

WS3: Guidelines and indicators for seamless care

WS4: Core outcome Set (COS) usable at discharge

13.00-13.30

Presentation of Workshop results and discussion. Program ends for non PCNE members

13.30-15.00

Possibility for Lunch

14.30-17.30

PCNE General Assembly (members only)

Abstracts must preferably be on one the symposium themes: Seamless pharmaceutical care, Drug-related problems, Medication review, Pharmaceutical care standards, or Core outcome sets.

Abstract submission has ended 15 November 2017 at 24.00h sharp.

Participants with accepted abstracts can register for early bird fee till 15th of December 2017.

A number of abstracts will be selected for oral presentations. As usual, there will be awards for the best poster, and the best oral communication, and all accepted and presented abstracts will be published in the International Journal of Clinical Pharmacy.

The conference is closed. You can not send in abstracts anymore.

Early Bird registration ends 15th December 2017

Registration ends 31 January 2018. 

Registration includes accomodation and breakfast & lunch, and the right to participate in two workshops (of course not parrallel). The fee for the conference can be found below. If you are not attending the social event, you need to take care of your own dinner on Friday Night.

If you decide to participate in the SEFAC-PCNE symposium on the 1st February, do not forget to register an extra night if necessary.

Registration form

Title:
Initials*:
Firstname*:
Lastname*:
Postal address*:
Postal code*:
City*:
Country*:
Email address*:
   
Institution:

Choose workshop

 
First choice workshop*:
Second choice workshop*:

Choose Accomodation and event options

** Please note that normal and early bird registration include accommodation, lunch with one drink on Friday, breakfast on Saturday, water during the sessions and coffee and tea during two breaks.

Desired room type*:


   
Arrival date*:
Departure date*:
   
Dinner and flamenco show at a Caseta de Feria, Fuengirola
   
Pharmaceutical Services Symposium (Thursday 17.00-19.00h)
   
Special diet required? (Which/how)
   
Remarks or questions:

Payment options

Payment time*:
Billing address equal to address
Name for invoice *:
Invoice address*:
Invoice Postal code*:
Invoice City*:
Invoice Country*:
   
   
 
Coupon (optional):